V. Peri

HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience

F. Merli, Gabriele De Luca, F. Cavallo, 2022, Journal of personalized medicine.

Molecular remission is an independent predictor of progression‐free survival in patients with Waldenström macroglobulinemia treated with chemo‐immunotherapy: Results from the FIL_BIOWM study

M. Merli, L. Arcaini, M. Varettoni, 2022, Hematological Oncology.

SARS-CoV-2 Infection in Patients With Waldenström’s Macroglobulinemia: A Multicenter International Cohort Study

C. Buske, L. Fornecker, F. Passamonti, 2023, HemaSphere.